期刊文献+

促肝细胞生长素肠溶胶囊治疗慢性乙型病毒性肝炎72例疗效观察 被引量:1

Effect of hepatocyte growth-promotion factors enteric-coated capsules on treatment of 72 cases with chronic viral hepatitis B
下载PDF
导出
摘要 目的观察促肝细胞生长素肠溶胶囊治疗慢性乙型病毒性肝炎的疗效。方法144例患者随机分为两组,72例常规治疗加促肝细胞生长素肠溶胶囊作为试验组,每日服2粒,每日3次,疗程12周;另72例常规治疗加促肝细胞生长素颗粒剂作为对照组,每次2袋,每日3次,疗程12周。服药前及服药时4、8、12周及治疗结束后4、8、12周测定肝功能、症状与体征变化。结果两组治疗后肝功能的多项指标均有明显改善,且治疗结束后12周肝功能尚持续改善;临床症状和体征也有明显改善,治疗组总有效率达76.57%。结论促肝细胞生长素肠溶胶囊能有效改善慢性乙型病毒性肝炎患者症状、体征与肝功能,且未见明显不良反应,使用安全。 OBJECTIVE To observation the clinical therapeatic effect of hepatocyte growth-promotion factors enteric-coated capsules in treatment chronic hepatitis B patients. METHODS 144 suffers were divided into random two sets,72 conventionality treatment add hepatocyte growth-promotion factors enteric-coated capsules as experimental group, taking 2 every time, and 3 times everyday for 12 weeks; the other 72 conventionality treatment add hepatocyte growth-promotion factors pelletized granule as control group,taking 2 bags of granules every time,3 times everyday for 12 weeks. Before and take the medicine for 4,8,12 weeks and after the treatment be over 4,8,12 weeks, the change of the liver function, symptom and objective sign were determined. RESULTS Several index signs of the liver function all had obvious improvement after the two treatments,and after the treatment be over 12 weeks,the liver function im- proved ; the clinical symptom and objective sign also had the obvious improvement, the total efficient of the treatment group amount to 76.57%. CONCLUSION Hepatocyte growth-promotion factors enteric-coated capsules can improve the liver function,symptom and objective sign of chronic hepatitis B patients without obvious advorse effect.
出处 《中国现代应用药学》 CAS CSCD 北大核心 2006年第1期68-71,共4页 Chinese Journal of Modern Applied Pharmacy
关键词 促肝细胞生长素肠溶胶囊 慢性乙型病毒性肝炎 hepatocyte growth-promoting factors enteric-coated capsules chronic viral hepatitis B
  • 相关文献

参考文献4

  • 1徐明红,胡伯鑫.肝细胞生长素研究进展[J].广东药学院学报,1995,11(1):39-41. 被引量:1
  • 2Medina J, Caveda L, Sanz-Cameno P,et al. Hepatocyte growth factor activates endothelial proangiogenic mechanisms relevant in chronic hepatitis C-associated neoangiogenesis [ J ]. J Hepatol,2003,38(5) :660.
  • 3Hwang TH, Yoon BC, Jeong JS, et al. A single administration of adcnoviral-mediatcd HGF cDNA permits survival of mice from acute hepatic failure [ J ]. Life Sci, 2003,72 ( 7 ) : 851.
  • 4Armbrust T,Batusic D,Xia L,et al. Early gene expression of hepatocyte growth factor in mononuclear phagocytes of rat liver after administration of carbon tetrachloride [ J ]. Liver, 2002,22 ( 6 ) :486.

二级参考文献6

同被引文献4

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部